Postinfusion covariates, including serum GM-CSF, IL-6, TNF-α, and CAR T cell expansion, ranked higher than pretreatment covariates, such as product T cell phenotype percentage and number of infused CAR T cells, for association with severe CRS and NE. The gene discussed is IL6; the disease is congenital rubella syndrome.